Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Canadian Government invests $175.6m in AbCellera’s Covid-19 response

AbCellera has received $175.6m through the Canadian Government’s Strategic Innovation Fund to support the development and manufacturing of antibody drugs against Covid-19, as well as allow for better preparedness for future pandemics.

Close
Close
Close

Go Top